MitoImmune Therapeutics

MitoImmune Therapeutics Inc. is a biotechnology company focused on drug development, leveraging the power of mitochondria and its proprietary technology targeting mitochondria to develop potentially groundbreaking therapies. Our mission is to extend healthy lifespan by developing treatments for necrotic and inflammatory diseases associated with mitochondrial dysfunction.